Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors is a research paper published in Genome Medicine (2021). On theSindex it has a DataRank of 0.848. It has been cited 24 times, with 16 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0.365
From 14 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 16 citers.
National Institutes of Health
Grant: R01CA177669
National Institutes of Health
Grant: U01CA196390
National Institutes of Health
Grant: U01CA212007
National Institutes of Health
Grant: F31 CA250135-01A1
National Institutes of Health
Grant: R01CA184926
National Institutes of Health
Grant: P50CA062924
National Institutes of Health
Grant: P30CA006973
National Institutes of Health
Grant: CA50633
National Institutes of Health
Grant: CA51008
National Institutes of Health
Grant: F30 CA239441
NCI NIH HHS
Grant: R01 CA197296
NCI NIH HHS
Grant: P01 CA247886
NCI NIH HHS
Grant: U01 CA253403
NCI NIH HHS
Grant: P30 CA051008
NCI NIH HHS
Grant: R50 CA243627
NCI NIH HHS
Grant: R01 CA050633
NCI NIH HHS
Grant: F31 CA250135
National Institutes of Health
Grant: 1R50CA243627-01
Comprehensive Analysis and Multi-Omics Data Integration for Cancer-Related Studies
National Institutes of Health
Grant: 1U01CA196390-01
Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry
National Institutes of Health
Grant: 5F31CA250135-02
T cell mechanisms of immunotherapy response in pancreatic ductal adenocarcinoma
National Institutes of Health
Grant: 5R01CA184926-03
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
National Institutes of Health
Grant: 5U01CA212007-03
Integrating bioinformatics into multiscale models for hepatocellular carcinoma
National Institutes of Health
Grant: 3P30CA006973-53S2
Regional Oncology Research Center
National Institutes of Health
Grant: 5R01CA177669-05
Dynamical Models of Cetuximab Resistance in HNSCC Based on Serial Genomics Data
National Institutes of Health
Grant: 5F30CA239441-03
The Potential Role of Firboblast Activation Protein as a Natural Killer Cell Immune Checkpoint in Pancreatic Cancer
National Institutes of Health
Grant: 5P50CA062924-25
SPORE in Gastrointestinal Cancers
FWCI
1.49
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors
Additional file 1 of Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors
Additional file 2 of Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors
Additional file 2 of Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors
Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors
Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors